Samantha Semenkow
Stock Analyst at Citigroup
(1.86)
# 3,266
Out of 5,090 analysts
61
Total ratings
38%
Success rate
-9.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Initiates: Buy | $102 | $56.90 | +79.26% | 1 | Nov 26, 2025 | |
| AGIO Agios Pharmaceuticals | Initiates: Buy | $38 | $27.73 | +37.04% | 1 | Nov 26, 2025 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Buy | $136 | $104.60 | +30.02% | 1 | Nov 25, 2025 | |
| ARGX argenx SE | Maintains: Buy | $1,041 → $1,124 | $901.17 | +24.73% | 7 | Nov 17, 2025 | |
| BHVN Biohaven | Maintains: Buy | $28 → $14 | $9.55 | +46.60% | 2 | Nov 13, 2025 | |
| PRME Prime Medicine | Maintains: Neutral | $5 → $4.25 | $3.74 | +13.64% | 5 | Nov 11, 2025 | |
| ROIV Roivant Sciences | Maintains: Buy | $25 → $26 | $20.97 | +23.99% | 3 | Nov 11, 2025 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $31 → $33 | $23.53 | +40.25% | 3 | Nov 7, 2025 | |
| BIOA BioAge Labs | Maintains: Buy | $10 → $15 | $11.61 | +29.20% | 5 | Oct 29, 2025 | |
| MLTX MoonLake Immunotherapeutics | Downgrades: Sell | $5 | $14.90 | -66.44% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $2.55 | +292.16% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.49 | +113.62% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.43 | +179.72% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $60 | $34.56 | +73.61% | 1 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.28 | +180.37% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $5.13 | +192.40% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $9.72 | +723.05% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.70 | +278.38% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.42 | +519.83% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $22.84 | +118.91% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.09 | +106.72% | 3 | Aug 9, 2023 |
Nektar Therapeutics
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $56.90
Upside: +79.26%
Agios Pharmaceuticals
Nov 26, 2025
Initiates: Buy
Price Target: $38
Current: $27.73
Upside: +37.04%
Rhythm Pharmaceuticals
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $104.60
Upside: +30.02%
argenx SE
Nov 17, 2025
Maintains: Buy
Price Target: $1,041 → $1,124
Current: $901.17
Upside: +24.73%
Biohaven
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $9.55
Upside: +46.60%
Prime Medicine
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.74
Upside: +13.64%
Roivant Sciences
Nov 11, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $20.97
Upside: +23.99%
Catalyst Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $23.53
Upside: +40.25%
BioAge Labs
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $11.61
Upside: +29.20%
MoonLake Immunotherapeutics
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $14.90
Upside: -66.44%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.55
Upside: +292.16%
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $7.49
Upside: +113.62%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.43
Upside: +179.72%
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $34.56
Upside: +73.61%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.28
Upside: +180.37%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $5.13
Upside: +192.40%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $9.72
Upside: +723.05%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.70
Upside: +278.38%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.42
Upside: +519.83%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $22.84
Upside: +118.91%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $27.09
Upside: +106.72%